Moderna, Inc (MRNA) Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

Moderna, Inc (NASDAQ: MRNA) FY 2026 Other Release

Newsdesk: